JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
47 hedge funds and large institutions have $51.2M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+11
Holders Change %
+30.56%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
15
Increased
16
Reduced
9
Closed
4
Calls
$682K
Puts
$1K
Net Calls
+$681K
Net Calls Change
+$681K
Top Buyers
| 1 |
AIC
AWM Investment Company
New York
|
+$1.52M |
| 2 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
+$1.27M |
| 3 |
Renaissance Technologies
New York
|
+$1.25M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$866K |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$812K |
Top Sellers
| 1 |
KAM
Krensavage Asset Management
New York
|
-$1.09M |
| 2 |
BlackRock
New York
|
-$1.06M |
| 3 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$1.02M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$560K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$69.8K |
